A breakthrough test developed by Indiana University School of Medicine researchers to measure pain in patients could help stem the tide of the opioid crisis in Indiana, and throughout the rest of the nation.
A study led by psychiatry professor Alexander Niculescu, MD, PhD and published this week in the high impact Nature journal Molecular Psychiatry tracked hundreds of participants at the Richard L. Roudebush VA Medical Center in Indianapolis to identify biomarkers in the blood that can help objectively determine how severe a patient’s pain is. The blood test, the first of its kind, would allow physicians far more accuracy in treating pain—as well as a better long-term look at the patient’s medical future.
“We have developed a prototype for a blood test that can objectively tell doctors if the patient is in pain, and how severe that pain is. It’s very important to have an objective measure of pain, as pain is a subjective sensation. Until now we have had to rely on patients self-reporting or the clinical impression the doctor has,” said Niculescu, who worked with other Department of Psychiatry researchers on the study. “When we started this work it was a farfetched idea. But the idea was to find a way to treat and prescribe things more appropriately to people who are in pain.”
During the study, researchers looked at biomarkers found in the blood—in this case molecules that reflect disease severity. Much like as glucose serves as a biomarker to diabetes, these biomarkers allow doctors to assess the severity of the pain the patient is experiencing, and provide treatment in an objective, quantifiable manner. With an opioid epidemic raging throughout the state and beyond, Niculescu said never has there been a more important time to administer drugs to patients responsibly.
“The opioid epidemic occurred because addictive medications were overprescribed due to the fact that there was no objective measure whether someone was in pain, or how severe their pain was,” Niculescu said. “Before, doctors weren’t being taught good alternatives. The thought was that this person says they are in pain, let’s prescribe it. Now people are seeing that this created a huge problem. We need alternatives to opioids, and we need to treat people in a precise fashion. This test we’ve developed allows for that.”
In addition to providing an objective measure of pain, Niculescu’s blood test helps physicians match the biomarkers in the patient’s blood with potential treatment options. Like a scene out of CSI, researchers utilize a prescription database—similar to fingerprint databases employed by the FBI—to match the pain biomarkers with profiles of drugs and natural compounds cataloged in the database.
“The biomarker is like a fingerprint, and we match it against this database and see which compound would normalize the signature,” said Niculescu, adding that often the best treatment identified is a non-opioid drug or compound. “We found some compounds that have been used for decades to treat other things pair the best with the biomarkers. We have been able to match biomarkers with existing medications, or natural compounds, which would reduce or eliminate the need to use the opioids.”
In keeping with the IU Grand Challenge Precision Health Initiative launched in June 2016, this study opens the door to precision medicine for pain. By treating and prescribing medicine more appropriately to the individual person, this prototype may help alleviate the dilemmas that have contributed to the current opioid epidemic.
“In any field, the goal is to match the patient to the right drug, which hopefully does a lot of good and very little harm,” Niculescu said. “But through precision health, by having lots of options geared toward the needs of specific patients, you prevent larger problems, like the opioid epidemic, from occurring.”
Additionally, study experts discovered biomarkers that not only match with non-addictive drugs that can treat pain, but can also help predict when someone might experience pain in the future—helping to determine if a patient is exhibiting chronic, long-term pain which might result in future emergency room visits.
“Through precision medicine you’re giving the patient treatment that is tailored directly to them and their needs,” Niculescu said. “We wanted first to find some markers for pain that are universal, and we were able to. We know, however, based on our data that there are some markers that work better for men, some that work better for women. It could be that there are some markers that work better for headaches, some markers that work better for fibromyalgia and so on. That is where we hope to go with future larger studies.”
The study was supported by an NIH Director’s New Innovator Award and a VA Merit Award. Moving forward, Niculescu’s group looks to secure more funding through grants or outside philanthropy to continue and accelerate these studies—with the hopes of personalizing the approach even more and moving toward a clinical application. A self-described longshot at the start, Niculescu said that the work his group has done could have a major impact on how doctors around the world treat pain in the future.
“It’s been a goal of many researchers and a dream to find biomarkers for pain,” Niculescu said. “We have come out of left field with an approach that had worked well in psychiatry for suicide and depression in previous studies. We applied it to pain, and we were successful. I give a lot of credit for that to my team at IU School of Medicine and the Indianapolis VA, as well as the excellent environment and support we have.”
The Latest on: Pain
via Google News
The Latest on: Pain
- Trump's Doctor Dismisses Speculation Of Chest Painon November 18, 2019 at 10:23 pm
Donald Trump's doctor on Monday denied reports that the US president had recently suffered chest pain after he attended an unannounced medical checkup in Washington. Trump, 73, spent just over an hour ...
- Tri-State Pain Institute sued over $1.7 million debton November 18, 2019 at 9:21 pm
Claims of a MRSA outbreak at the Tri-State Pain Institute have led to a series of lawsuits against the the clinic and its founder, Joseph M. Thomas, M.D. Court records show that Thomas and the pain ...
- What to know about colon painon November 18, 2019 at 9:07 pm
The colon is another name for the large intestine. It is an important part of the digestive system. Sometimes, a person can experience pain in this area. After food goes through the stomach, it enters ...
- Why Lady Gaga Sees ‘Pain’ When She Looks At Her Oscar For ‘Shallow’on November 18, 2019 at 5:45 pm
“When I won the Oscar for “Shallow,” I looked at it, and a reporter asked me, ‘When you look at that Oscar, what do you see?’ And I said, ‘I see a lot of pain.’ And I wasn’t lying in that moment,” she ...
- Neuropathy patient says numbness and pain are gone with advanced treatmenton November 18, 2019 at 3:07 pm
HOUSTON — Do you suffer from nerve pain daily? If medications are masking the symptoms and not improving your quality of life, there is hope. A proprietary treatment by Dr. Bao Thai of Advanced Nerve ...
- Bears’ Nagy says Trubisky lifted because of hip painon November 18, 2019 at 2:08 pm
LAKE FOREST, Ill. (AP) Chicago Bears coach Matt Nagy insisted he pulled Mitchell Trubisky near the end of Sunday’s loss to the Los Angeles Rams because of pain in his right hip and not because he’s ...
- Seeing Palestinian Pain as Art at the Other Israeli Film Festival (Guest Blog)on November 18, 2019 at 10:14 am
As I sit here, writing about Palestinian films and The Other Israeli Film Festival, rockets lobbed from Gaza are falling once again in Israel, wreaking havoc and terror. The rockets do not fall on ...
- Sensible Change Minnesota Seeks Adding Chronic Pain To Conditions OK’d For Medical Marijuanaon November 18, 2019 at 10:09 am
MINNEAPOLIS (WCCO) — Medical cannabis could be available to more Minnesotans. A push is underway to have “chronic pain” as a covered condition. Medical cannabis was signed into law in 2014. It covers ...
- Stefanos Tsitsipas prepared for 'pain' to break Big Three's dominanceon November 18, 2019 at 5:14 am
Greek tennis star Stefanos Tsitsipas hopes to use his 2019 ATP Finals win as a springboard to breaking the Big Three;s grand slam dominance in 2020. Like us on Facebook to see similar stories Please ...
- Pain still prominent two years after police fatally shot Bijan Ghaisaron November 17, 2019 at 6:57 pm
WASHINGTON - Do two years dull the pain of losing a child? Do the tears flow less easily, two years after learning that your son was shot by police, followed by 10 days of watching him in an ...
via Bing News